Drugs / Bacillus Calmette Guerin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00003023 Background | Mar 1997 → Jan 2005 | neuroblastoma, sarcoma | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bacillus Calmette Guerin | “Bacillus Calmette Guerin (BCG) adjuvant” NCT00003023 ↗ |
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00003023 ↗ |
| Modality | Vaccine | “BCG vaccine” NCT00003023 ↗ |